Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Sievers

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Neuro-Oncology|December 11, 2023
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trialMaximilian Y Deng, Sybren L N Maas, Felix Hinz, et al.
Acta Neuropathologica|September 8, 2021
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomasElmar Kirches, Felix Sahm, Andrey Korshunov, et al.
Acta Neuropathologica|July 7, 2019
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusionsDamian Stichel, Daniel Schrimpf, Belén Casalini, et al.
Brain Pathology (Zurich, Switzerland)|July 27, 2021
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterpartsArnault Tauziède-Espariat, Philipp Sievers, Frédérique Larousserie, et al.
Acta Neuropathologica|November 18, 2019
YAP1-fusions in pediatric NF2-wildtype meningiomaPhilipp Sievers, Jason Chiang, Daniel Schrimpf, et al.
Cell Genomics|May 24, 2024
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeH Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.
Theranostics|October 14, 2021
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastomaVerena Panitz, Saša Končarević, Ahmed Sadik, et al.
Neuro-Oncology|May 27, 2025
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profilesMaximilian Y Deng, Sybren L N Maas, Günes Anil, et al.
Neuro-Oncology Advances|June 9, 2023
Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classificationMaximilian Y Deng, Felix Hinz, Sybren L N Maas, et al.
Acta Neuropathologica|November 30, 2019
Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic markerAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Neuro-Oncology|December 11, 2023
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trialMaximilian Y Deng, Sybren L N Maas, Felix Hinz, et al.
Acta Neuropathologica|September 8, 2021
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomasElmar Kirches, Felix Sahm, Andrey Korshunov, et al.
Acta Neuropathologica|July 7, 2019
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusionsDamian Stichel, Daniel Schrimpf, Belén Casalini, et al.
Brain Pathology (Zurich, Switzerland)|July 27, 2021
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterpartsArnault Tauziède-Espariat, Philipp Sievers, Frédérique Larousserie, et al.
Acta Neuropathologica|November 18, 2019
YAP1-fusions in pediatric NF2-wildtype meningiomaPhilipp Sievers, Jason Chiang, Daniel Schrimpf, et al.
Cell Genomics|May 24, 2024
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeH Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.
Theranostics|October 14, 2021
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastomaVerena Panitz, Saša Končarević, Ahmed Sadik, et al.
Neuro-Oncology|May 27, 2025
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profilesMaximilian Y Deng, Sybren L N Maas, Günes Anil, et al.
Neuro-Oncology Advances|June 9, 2023
Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classificationMaximilian Y Deng, Felix Hinz, Sybren L N Maas, et al.
Acta Neuropathologica|November 30, 2019
Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic markerAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Pageof 13